Federal
Ensuring Compliance Against Drug Diversion Act of 2021
Source: Congress.gov ·
692 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
117TH CONGRESS
1ST SESSION
S. 1286
To amend the Controlled Substances Act to provide for the modification,
transfer, and termination of a registration to manufacture, distribute,
or dispense controlled substances or list I chemicals, and for other
purposes.
IN THE SENATE OF THE UNITED STATES
APRIL 21, 2021
Mr. CORNYN (for himself and Mrs. FEINSTEIN) introduced the following bill;
which was read twice and referred to the Committee on the Judiciary
A BILL
To amend the Controlled Substances Act to provide for the
modification, transfer, and termination of a registration
to manufacture, distribute, or dispense controlled sub-
stances or list I chemicals, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Ensuring Compliance
4
Against Drug Diversion Act of 2021’’.
5
VerDate Sep 11 2014
04:45 May 19, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S1286.IS
S1286
kjohnson on DSK79L0C42PROD with BILLS
2
•S 1286 IS
SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF
1
REGISTRATION
TO
MANUFACTURE,
DIS-
2
TRIBUTE, OR DISPENSE CONTROLLED SUB-
3
STANCES.
4
Subsection (a) of section 302 of the Controlled Sub-
5
stances Act (21 U.S.C. 822) is amended by adding at the
6
end the following new paragraph:
7
‘‘(3)(A) Except as provided in subparagraph (C), the
8
registration of any registrant under this title to manufac-
9
ture, distribute, or dispense controlled substances or list
10
I chemicals terminates if and when such registrant—
11
‘‘(i) dies;
12
‘‘(ii) ceases legal existence;
13
‘‘(iii) discontinues business or professional prac-
14
tice; or
15
‘‘(iv) surrenders such registration.
16
‘‘(B) In the case of such a registrant who ceases legal
17
existence or discontinues business or professional practice,
18
such registrant shall promptly notify the Attorney General
19
in writing of such fact.
20
‘‘(C) No registration under this title to manufacture,
21
distribute, or dispense controlled substances or list I
22
chemicals, and no authority conferred thereby, may be as-
23
signed or otherwise transferred except upon such condi-
24
tions as the Attorney General may specify and then only
25
pursuant to written consent. A registrant to whom a reg-
26
VerDate Sep 11 2014
04:45 May 19, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S1286.IS
S1286
kjohnson on DSK79L0C42PROD with BILLS
3
•S 1286 IS
istration is assigned or transferred pursuant to the pre-
1
ceding sentence may not manufacture, distribute, or dis-
2
pense controlled substances or list I chemicals pursuant
3
to such registration until the Attorney General receives
4
such written consent.
5
‘‘(D) In the case of a registrant under this title to
6
manufacture, distribute, or dispense controlled substances
7
or list I chemicals desiring to discontinue business or pro-
8
fessional practice altogether or with respect to controlled
9
substances and list I chemicals (without assigning or
10
transferring such business or professional practice to an-
11
other entity), such registrant shall return to the Attorney
12
General for cancellation—
13
‘‘(i) the registrant’s certificate of registration;
14
‘‘(ii) any unexecuted order forms in the reg-
15
istrant’s possession; and
16
‘‘(iii) any other documentation that the Attor-
17
ney General may require.’’.
18
SEC. 3. DETERMINATION OF BUDGETARY EFFECTS.
19
The budgetary effects of this Act, for the purpose of
20
complying with the Statutory Pay-As-You-Go Act of 2010,
21
shall be determined by reference to the latest statement
22
titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this
23
Act, submitted for printing in the Congressional Record
24
by the Chairman of the House Budget Committee, pro-
25
VerDate Sep 11 2014
04:45 May 19, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S1286.IS
S1286
kjohnson on DSK79L0C42PROD with BILLS
4
•S 1286 IS
vided that such statement has been submitted prior to the
1
vote on passage.
2
Æ
VerDate Sep 11 2014
04:45 May 19, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\S1286.IS
S1286
kjohnson on DSK79L0C42PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.